|
1.
|
Suzuki O, Hirsch B, Abe M, Dürkop H and
Stein H: Galectin-1-mediated cell death is increased by
CD30-induced signaling in anaplastic large cell lymphoma cells but
not in Hodgkin lymphoma cells. Lab Invest. 92:191–199. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Suzuki O, Nozawa Y and Abe M: Regulatory
roles of altered N-and O-glycosylation of CD45 in
galectin-1-induced cell death in human diffuse large B cell
lymphoma. Int J Oncol. 26:1063–1068. 2005.
|
|
3.
|
Earl LA, Bi S and Baum LG: N- and
O-glycans modulate galectin-1 binding, CD45 signaling, and T cell
death. J Biol Chem. 285:2232–2244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Rabinovich GA, Rubinstein N and Toscano
MA: Role of galectins in inflammatory and immunomodulatory
processes. Biochim Biophys Acta. 1572:274–284. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Allen HJ, Sucato D, Gottstine S, Kisailus
E, Nava H, Petrelli N, Castillo N and Wilson D: Localization of
endogenous beta-galactoside-binding lectin in human cells and
tissues. Tumor Biol. 12:52–60. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Skrincosky DM, Allen HJ and Bernacki RJ:
Galaptin-mediated adhesion of human ovarian carcinoma A121 cells
and detection of cellular galaptin-binding glycoproteins. Cancer
Res. 53:2667–2675. 1993.PubMed/NCBI
|
|
7.
|
Suzuki O, Nozawa Y and Abe M: The
regulatory roles of cell surface sialylation and N-glycans in human
B cell lymphoma cell adhesion to galectin-1. Int J Oncol.
28:155–160. 2006.PubMed/NCBI
|
|
8.
|
Landemarre L, Cancellieri P and Duverger
E: Cell surface lectin array: parameters affecting cell glycan
signature. Glycoconj J. 30:195–203. 2013. View Article : Google Scholar
|
|
9.
|
Suzuki O, Nozawa Y, Kawaguchi T and Abe M:
Phaseolus vulgaris leukoagglutinationg lectin-binding reactivity in
human diffuse large B cell lymphoma and its relevance to the
patient’s clinical outcome: lectin histochemistry and lectin blot
analysis. Pathol Int. 49:874–880. 1999.PubMed/NCBI
|
|
10.
|
Albini A, Iwamoto Y, Kleinman HK, Martin
GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay
for quantitating the invasive potential of tumor cells. Cancer Res.
47:3239–3245. 1987.PubMed/NCBI
|
|
11.
|
Horiguchi N, Arimoto K, Mizutani A,
Endo-Ichikawa Y, Nakada H and Taketani S: Galectin-1 induces cell
adhesion to the extracellular matrix and apoptosis of non-adherent
human colon cancer Colo201 cells. J Biochem. 134:869–874. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Espelt MV, Croci DO, Bacigalupo ML,
Carabias P, Manzi M, Elola MT, Muñoz MC, Dominici FP,
Wolfenstein-Todel C, Rabinovich GA and Troncoso MF: Novel roles of
galectin-1 in hepatocellular carcinoma cell adhesion, polarization,
and in vivo tumor growth. Hepatology. 53:2097–2106. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Sanchez-Ruderisch H, Detjen KM, Welzel M,
André S, Fischer C, Gabius HJ and Rosewicz S: Galectin-1 sensitizes
carcinoma cells to anoikis via the fibronectin receptor
α5β1-integrin. Cell Death Differ. 18:806–816. 2011.PubMed/NCBI
|
|
14.
|
Zhao XY, Chen TT, Xia L, Guo M, Xu Y, Yue
F, Jiang Y, Chen GQ and Zhao KW: Hypoxia inducible factor-1
mediates expression of galectin-1: the potential role in
migration/invasion of colorectal cancer cells. Carcinogenesis.
31:1367–1375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zhuo Y and Bellis SL: Emerging role of
alpha2,6-sialic acid as a negative regulator of galectin binding
and function. J Biol Chem. 286:5935–5941. 2011. View Article : Google Scholar
|
|
16.
|
Cui H, Lin Y, Yue L, Zhao X and Liu J:
Differential expression of the α2,3-sialic acid residues in breast
cancer is associated with metastatic potential. Oncol Rep.
25:1365–1371. 2011.
|
|
17.
|
Wang FL, Cui SX, Sun LP, Qu XJ, Xie YY,
Zhou L, Mu YL, Tang W and Wang YS: High expression of alpha 2,
3-linked sialic acid residues is associated with the metastatic
potential of human gastric cancer. Cancer Detect Prev. 32:437–443.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Dall’Olio F, Chiricolo M, Ceccarelli C,
Minni F, Marrano D and Santini D: Beta-galactoside alpha2,6
sialyltransferase in human colon cancer: contribution of multiple
transcripts to regulation of enzyme activity and reactivity with
Sambucus nigra agglutinin. Int J Cancer. 88:58–65. 2000.PubMed/NCBI
|
|
19.
|
Mondal S, Chandra S and Mandal C: Elevated
mRNA level of hST6Gal I and hST3Gal V positively correlates with
the high risk of pediatric acute leukemia. Leuk Res. 34:463–470.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Lee M, Park JJ, Ko YG and Lee YS: Cleavage
of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored
ST6Gal I-mediated sialylation of integrin β1 and migration in colon
cancer cells. Radiat Oncol. 7:472012.PubMed/NCBI
|
|
21.
|
Suzuki O, Nozawa Y, Kawaguchi T and Abe M:
UDP-GlcNAc2-epimerase regulates cell surface sialylation and cell
adhesion to extracellular matrix in Burkitt’s lymphoma. Int J
Oncol. 20:1005–1011. 2002.PubMed/NCBI
|
|
22.
|
Perillo NL, Pace KE, Seilhamer JJ and Baum
LG: Apoptosis of T cells mediated by galectin-1. Nature.
378:736–739. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Yamamoto H, Nishi N, Shoji H, Itoh A, Lu
LH, Hirashima M and Nakamura T: Induction of cell adhesion by
galectin-8 and its target molecules in Jurkat T-cells. J Biochem.
143:311–324. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Huang C, Jacobson K and Schaller MD: MAP
kinases and cell migration. J Cell Sci. 117:4619–4628. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Tybulewicz VL and Henderson RB: Rho family
GTPases and their regulators in lymphocytes. Nat Rev Immunol.
9:630–644. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26.
|
de Oliveira JT, de Matos AJ, Santos AL,
Pinto R, Gomes J, Hespanhol V, Chammas R, Manninen A, Bernardes ES,
Albuquerque Reis C, Rutteman G and Gärtner F: Sialylation regulates
galectin-3/ligand interplay during mammary tumour progression - a
case of targeted uncloaking. Int J Dev Biol. 55:823–834.
2011.PubMed/NCBI
|
|
27.
|
Varki A, Cummings RD, Esko JD, et al:
Glycomics. Essentials of Glycobiology. 2nd edition. Cold Spring
Harbor Laboratory Press; Cold Spring Harbor, NY: 2009
|
|
28.
|
Kamper P, Ludvigsen M, Bendix K,
Hamilton-Dutoit S, Rabinovich GA, Møller MB, Nyengaard JR, Honoré B
and d’Amore F: Proteomic analysis identifies galectin-1 as a
predictive biomarker for relapsed/refractory disease in classical
Hodgkin lymphoma. Blood. 117:6638–6649. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Rodig SJ, Ouyang J, Juszczynski P, Currie
T, Law K, Neuberg DS, Rabinovich GA, Shipp MA and Kutok JL:
AP1-dependent galectin-1 expression delineates classical Hodgkin
and anaplastic large cell lymphomas from other lymphoid
malignancies with shared molecular features. Clin Cancer Res.
14:3338–3344. 2008. View Article : Google Scholar
|
|
30.
|
Juszczynski P, Ouyang J, Monti S, Rodig
SJ, Takeyama K, Abramson J, Chen W, Kutok JL, Rabinovich GA and
Shipp MA: The AP1-dependent secretion of galectin-1 by Reed
Sternberg cells fosters immune privilege in classical Hodgkin
lymphoma. Proc Natl Acad Sci USA. 104:13134–13139. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Banh A, Zhang J, Cao H, Bouley DM, Kwok S,
Kong C, Giaccia AJ, Koong AC and Le QT: Tumor galectin-1 mediates
tumor growth and metastasis through regulation of T-cell apoptosis.
Cancer Res. 71:4423–4431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Hahn HP, Pang M, He J, Hernandez JD, Yang
R-Y, Li L, Wang X, Liu F-T and Baum LG: Galectin-1 induces nuclear
translocation of endonuclease G in caspase- and cytochrome
c-independent T cell death. Cell Death Differ. 11:1277–1286. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Fouillit M, Joubert-Caron R, Poirier F,
Bourin P, Monostori E, Levi-Strauss M, Raphael M, Bladier D and
Caron M: Regulation of CD45-induced signaling by galectin-1 in
Burkitt lymphoma B cells. Glycobiology. 10:413–419. 2000.
View Article : Google Scholar : PubMed/NCBI
|
